FT Global Pharma and Biotech Conference

5 - 6 November 2018, London

Embracing Disruption for a New Era in Healthcare

The 36th Financial Times Annual Global Pharmaceutical and Biotechnology Conference, brings together the industry’s top executives and visionaries to explore the latest trends impacting the global life sciences industry, including the latest trends in gene-based therapies, the rise of China, big data and AI.

25% discount for ICON clients

As a lead sponsor, ICON is pleased to offer clients and other third parties, a 25% discount of the registration fee (a saving of £475 off the full registration price of £1,899).

Participating ICON Executives include:

Dr. Nuala Murphy

Dr. Nuala Murphy

President of ICON Clinical Services

Dr. Nuala Murphy will deliver a keynote speech.

Dr. Colin Orford

Senior Vice President, Drug Development Services & Consulting

Dr. Colin Orford will patricpate in a panel discussion: Innovate Like a Start-Up: A New Future for R&D?

What are the challenges facing R&D, and the strategies and approaches to reinvigorate drug development and research?

Just some of the industry’s leading executives participating include:

  • Christophe Weber, President  & CEO, Takeda
  • Richard Francis, CEO, Sandoz
  • Dr Hal Barron, Chief Scientific Officer and President, R&D, GlaxoSmithKline
  • Udit Batra, CEO, Life Sciences, Merck
  • Mene Pangalos, Executive Vice President, AstraZeneca
  • Mark Mallon, Executive Vice President, Global Product and Portfolio Strategy, AstraZeneca
  • Stephen Moran, Global Head of Strategy, Novartis